97 related articles for article (PubMed ID: 18248389)
21. Prevaccination distribution of human papillomavirus types in Italian women with high-risk lesions and cervical neoplasia.
De Francesco MA; Gargiulo F; Schreiber C; Ciravolo G; Salinaro F; Manca N
Intervirology; 2010; 53(6):417-25. PubMed ID: 20606464
[TBL] [Abstract][Full Text] [Related]
22. Current studies on human papillomavirus in Saudi Arabia.
Alhamlan FS; Al-Qahtani AA; Al-Ahdal MN
J Infect Dev Ctries; 2015 Jul; 9(6):571-6. PubMed ID: 26142665
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus type-specific prevalence in women referred for colposcopic examination in Beijing.
Ding X; Liu Z; Su J; Yan D; Sun W; Zeng Z
J Med Virol; 2014 Nov; 86(11):1937-43. PubMed ID: 25132373
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus detection in cervical carcinoma tissues and paraaortic lymph nodes by the polymerase chain reaction.
Park JS; Chee YH; Namkoong SE; Han SK; Kim TE; Lee HY; Kim SJ
Gynecol Oncol; 1994 Jun; 53(3):344-51. PubMed ID: 8206408
[TBL] [Abstract][Full Text] [Related]
25. Correlation of viral factors with cervical cancer in Taiwan.
Yang YY; Koh LW; Tsai JH; Tsai CH; Wong EF; Lin SJ; Yang CC
J Microbiol Immunol Infect; 2004 Oct; 37(5):282-7. PubMed ID: 15497009
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of human papillomavirus genotyping.
Choi YJ; Park JS
J Gynecol Oncol; 2016 Mar; 27(2):e21. PubMed ID: 26768784
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of human papillomavirus infection in esophageal and cervical cancers in the high incidence area for the two diseases from 2007 to 2009 in Linzhou of Henan Province, Northern China.
Liu HY; Zhou SL; Ku JW; Zhang DY; Li B; Han XN; Fan ZM; Cui JL; Lin HL; Guo ET; Chen X; Yuan Y; Han JJ; Zhang W; Zhang LQ; Zhou FY; Liao SX; Hong JY; Wang LD
Arch Virol; 2014 Jun; 159(6):1393-401. PubMed ID: 24385156
[TBL] [Abstract][Full Text] [Related]
28. comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.
van Ham MA; Bakkers JM; Harbers GK; Quint WG; Massuger LF; Melchers WJ
J Clin Microbiol; 2005 Jun; 43(6):2662-7. PubMed ID: 15956381
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
Iwasawa A; Nieminen P; Lehtinen M; Paavonen J
Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095
[TBL] [Abstract][Full Text] [Related]
30. Genetic diversity of human papillomavirus types 35, 45 and 58 in cervical cancer in Brazil.
Basto DL; Vidal JP; Pontes VB; Felix SP; Pinto LC; Soares BM; Martins LF; Correa FM; Montenegro RC; Chaves CBP; Almeida LM; Moreira MÂM
Arch Virol; 2017 Sep; 162(9):2855-2860. PubMed ID: 28597068
[TBL] [Abstract][Full Text] [Related]
31. High prevalence of high-risk oncogenic human papillomaviruses harboring atypical distribution in women of childbearing age living in Libreville, Gabon.
Si-Mohamed A; Ndjoyi-Mbiguino A; Cuschieri K; Onas IN; Colombet I; Ozouaki F; Goff JL; Cubie H; Bélec L
J Med Virol; 2005 Nov; 77(3):430-8. PubMed ID: 16173023
[TBL] [Abstract][Full Text] [Related]
32. Physical status and expression of HPV genes in cervical cancers.
Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
[TBL] [Abstract][Full Text] [Related]
33. [Molecular variants of human papillomaviruses types 16, 18, and 45 in tumors of the uterine cervix in Mexico].
Lizano M; García-Carrancá A
Gac Med Mex; 1997; 133 Suppl 1():43-8. PubMed ID: 9504102
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus detection using the Abbott RealTime high-risk HPV tests compared with conventional nested PCR coupled to high-throughput sequencing of amplification products in cervical smear specimens from a Gabonese female population.
Moussavou-Boundzanga P; Koumakpayi IH; Labouba I; Leroy EM; Belembaogo E; Berthet N
Virol J; 2017 Dec; 14(1):241. PubMed ID: 29268766
[TBL] [Abstract][Full Text] [Related]
35. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica.
Herrero R; Castle PE; Schiffman M; Bratti MC; Hildesheim A; Morales J; Alfaro M; Sherman ME; Wacholder S; Chen S; Rodriguez AC; Burk RD
J Infect Dis; 2005 Jun; 191(11):1796-807. PubMed ID: 15871111
[TBL] [Abstract][Full Text] [Related]
36. Human papilloma virus molecular profile and mechanisms of cancerogenesis: a review.
Deligeoroglou E; Christopoulos P; Aravantinos L; Papadias K
Eur J Gynaecol Oncol; 2009; 30(2):128-32. PubMed ID: 19480239
[TBL] [Abstract][Full Text] [Related]
37. Susceptibility to cervical cancer: an overview.
de Freitas AC; Gurgel AP; Chagas BS; Coimbra EC; do Amaral CM
Gynecol Oncol; 2012 Aug; 126(2):304-11. PubMed ID: 22484226
[TBL] [Abstract][Full Text] [Related]
38. A binary (Bethesda) system for classifying cervical cancer precursors: criteria, reproducibility, and viral correlates.
Genest DR; Stein L; Cibas E; Sheets E; Zitz JC; Crum CP
Hum Pathol; 1993 Jul; 24(7):730-6. PubMed ID: 8391511
[TBL] [Abstract][Full Text] [Related]
39. Evolution and classification of oncogenic human papillomavirus types and variants associated with cervical cancer.
Chen Z; de Freitas LB; Burk RD
Methods Mol Biol; 2015; 1249():3-26. PubMed ID: 25348294
[TBL] [Abstract][Full Text] [Related]
40. A Synopsis on the Role of Human Papilloma Virus Infection in Cervical Cancer.
Saeed M; Alshammari FD; Alam MJ; Sarim KM; Ahmad K; Hussain T; Khan M; Kamal MA; Kausar MA; Alkreathy HM; Faisal SM; Ashraf GM
Curr Drug Metab; 2018; 19(9):798-805. PubMed ID: 29512446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
